← Back to Clinical Trials
Recruiting Phase 2 NCT05304065
Safe Treatment for Emergency Presentation for Suicidal Ideation and Behavior in Youth
Trial Parameters
Condition Suicide
Sponsor University of California, Los Angeles
Study Type INTERVENTIONAL
Phase Phase 2
Enrollment 1,600
Sex ALL
Min Age 13 Years
Max Age 24 Years
Start Date 2022-10-17
Completion 2026-12-31
Interventions
SAFETY-A within usual ED CareCombined SAFETY-A within usual ED Care + CLASP Therapeutic Follow-Up Contacts
Brief Summary
This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 13-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. Outcomes will be monitored at baseline and at 3, 6 \& 12 month follow-up assessments.
Eligibility Criteria
Inclusion Criteria: * age 13-24; * past-week suicidal behavior or ideation with plan or intent Exclusion Criteria: * symptoms or illness that precludes informed consent or engagement in study procedures (e.g., active psychosis; drug dependence, no locator information); * youth not fluent in English * parent not fluent in English or Spanish.
Related Trials
NCT06406972
Brief Admission by Self-referral for Individuals With Self-harm: Effects on Compulsory Care
View Trial →
NCT06770101
Suicide Assessment and Feasible Evidence-based Treatments for Youth Living With HIV in Lilongwe
View Trial →
NCT06375083
Computerized Cognitive Behavioral Therapies for Suicide Prevention and Depression
View Trial →